| G0I | Name: | 1-[4-ethyl-2-methyl-5-[2-(piperazin-1-ylmethyl)-1,3-thiazol-4-yl]-1~{H}-pyrrol-3-yl]ethanone | Formula: | C17 H24 N4 O S | SMILES: | CCc1c([nH]c(C)c1C(C)=O)c2csc(CN3CCNCC3)n2 | InChi: | InChI=1S/C17H24N4OS/c1-4-13-16(12(3)22)11(2)19-17(13)14-10-23-15(20-14)9-21-7-5-18-6-8-21/h10,18-19H,4-9H2,1-3H3 | Definition date: | 2022-01-26 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 1-[4-ethyl-2-methyl-5-[2-(piperazin-1-ylmethyl)-1,3-thiazol-4-yl]-1~{H}-pyrrol-3-yl]ethanone |
|
| G1U | Name: | 1-[5-[2-[(4-azanylpiperidin-1-yl)methyl]-1,3-thiazol-4-yl]-4-ethyl-2-methyl-1~{H}-pyrrol-3-yl]ethanone | Formula: | C18 H26 N4 O S | SMILES: | CCc1c([nH]c(C)c1C(C)=O)c2csc(CN3CCC(N)CC3)n2 | InChi: | InChI=1S/C18H26N4OS/c1-4-14-17(12(3)23)11(2)20-18(14)15-10-24-16(21-15)9-22-7-5-13(19)6-8-22/h10,13,20H,4-9,19H2,1-3H3 | Definition date: | 2022-01-26 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 1-[5-[2-[(4-azanylpiperidin-1-yl)methyl]-1,3-thiazol-4-yl]-4-ethyl-2-methyl-1~{H}-pyrrol-3-yl]ethanone |
|
| G2U | Name: | 3-[[4-(4-ethanoyl-3,5-dimethyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]methyl]imidazolidine-2,4-dione | Formula: | C15 H16 N4 O3 S | SMILES: | CC(=O)c1c(C)[nH]c(c1C)c2csc(CN3C(=O)CNC3=O)n2 | InChi: | InChI=1S/C15H16N4O3S/c1-7-13(9(3)20)8(2)17-14(7)10-6-23-11(18-10)5-19-12(21)4-16-15(19)22/h6,17H,4-5H2,1-3H3,(H,16,22) | Definition date: | 2022-01-26 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 3-[[4-(4-ethanoyl-3,5-dimethyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]methyl]imidazolidine-2,4-dione |
|
| GEJ | Name: | (2R)-1-[4-(4-ethanoyl-3-ethyl-5-methyl-1H-pyrrol-2-yl)-1,3-thiazol-2-yl]-N-[2-(1,2-oxazol-5-yl)ethyl]piperazine-2-carboxamide | Formula: | C22 H28 N6 O3 S | SMILES: | CCc1c([nH]c(C)c1C(C)=O)c2csc(n2)N3CCNC[CH]3C(=O)NCCc4oncc4 | InChi: | InChI=1S/C22H28N6O3S/c1-4-16-19(14(3)29)13(2)26-20(16)17-12-32-22(27-17)28-10-9-23-11-18(28)21(30)24-7-5-15-6-8-25-31-15/h6,8,12,18,23,26H,4-5,7,9-11H2,1-3H3,(H,24,30)/t18-/m1/s1 | Definition date: | 2022-02-02 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | (2~{R})-1-[4-(4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]-~{N}-[2-(1,2-oxazol-5-yl)ethyl]piperazine-2-carboxamide |
|
| GGQ | Name: | 1-[2-methyl-5-(2-piperazin-1-yl-1,3-thiazol-4-yl)-4-[3,3,3-tris(fluoranyl)propyl]-1~{H}-pyrrol-3-yl]ethanone | Formula: | C17 H21 F3 N4 O S | SMILES: | CC(=O)c1c(C)[nH]c(c1CCC(F)(F)F)c2csc(n2)N3CCNCC3 | InChi: | InChI=1S/C17H21F3N4OS/c1-10-14(11(2)25)12(3-4-17(18,19)20)15(22-10)13-9-26-16(23-13)24-7-5-21-6-8-24/h9,21-22H,3-8H2,1-2H3 | Definition date: | 2022-02-02 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 1-[2-methyl-5-(2-piperazin-1-yl-1,3-thiazol-4-yl)-4-[3,3,3-tris(fluoranyl)propyl]-1~{H}-pyrrol-3-yl]ethanone |
|
| GHL | Name: | (2~{R})-~{N}-(2,2-dimethylpropyl)-1-[4-(4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]piperazine-2-carboxamide | Formula: | C22 H33 N5 O2 S | SMILES: | CCc1c([nH]c(C)c1C(C)=O)c2csc(n2)N3CCNC[CH]3C(=O)NCC(C)(C)C | InChi: | InChI=1S/C22H33N5O2S/c1-7-15-18(14(3)28)13(2)25-19(15)16-11-30-21(26-16)27-9-8-23-10-17(27)20(29)24-12-22(4,5)6/h11,17,23,25H,7-10,12H2,1-6H3,(H,24,29)/t17-/m1/s1 | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | (2~{R})-~{N}-(2,2-dimethylpropyl)-1-[4-(4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]piperazine-2-carboxamide |
|
| GI0 | Name: | 3-methyl-1-[2-[4-[(4-methyl-1~{H}-pyrazol-3-yl)methyl]piperazin-1-yl]-1,3-thiazol-4-yl]-2,5,6,7-tetrahydroisoindol-4-one | Formula: | C21 H26 N6 O S | SMILES: | Cc1[nH]c(c2CCCC(=O)c12)c3csc(n3)N4CCN(CC4)Cc5n[nH]cc5C | InChi: | InChI=1S/C21H26N6OS/c1-13-10-22-25-16(13)11-26-6-8-27(9-7-26)21-24-17(12-29-21)20-15-4-3-5-18(28)19(15)14(2)23-20/h10,12,23H,3-9,11H2,1-2H3,(H,22,25) | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 3-methyl-1-[2-[4-[(4-methyl-1~{H}-pyrazol-3-yl)methyl]piperazin-1-yl]-1,3-thiazol-4-yl]-2,5,6,7-tetrahydroisoindol-4-one |
|
| GI7 | Name: | 1-[4-(4-ethanoylpiperazin-1-yl)phenyl]guanidine | Formula: | C13 H19 N5 O | SMILES: | CC(=O)N1CCN(CC1)c2ccc(NC(N)=N)cc2 | InChi: | InChI=1S/C13H19N5O/c1-10(19)17-6-8-18(9-7-17)12-4-2-11(3-5-12)16-13(14)15/h2-5H,6-9H2,1H3,(H4,14,15,16) | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 1-[4-(4-ethanoylpiperazin-1-yl)phenyl]guanidine |
|
| GIE | Name: | 1-[4-ethyl-2-methyl-5-(2-piperazin-1-yl-1,3-thiazol-4-yl)-1~{H}-pyrrol-3-yl]ethanone | Formula: | C16 H22 N4 O S | SMILES: | CCc1c([nH]c(C)c1C(C)=O)c2csc(n2)N3CCNCC3 | InChi: | InChI=1S/C16H22N4OS/c1-4-12-14(11(3)21)10(2)18-15(12)13-9-22-16(19-13)20-7-5-17-6-8-20/h9,17-18H,4-8H2,1-3H3 | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 1-[4-ethyl-2-methyl-5-(2-piperazin-1-yl-1,3-thiazol-4-yl)-1~{H}-pyrrol-3-yl]ethanone |
|
| GIJ | Name: | (2~{R})-1-[4-(4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]-~{N}-[3,3,3-tris(fluoranyl)propyl]piperazine-2-carboxamide | Formula: | C20 H26 F3 N5 O2 S | SMILES: | CCc1c([nH]c(C)c1C(C)=O)c2csc(n2)N3CCNC[CH]3C(=O)NCCC(F)(F)F | InChi: | InChI=1S/C20H26F3N5O2S/c1-4-13-16(12(3)29)11(2)26-17(13)14-10-31-19(27-14)28-8-7-24-9-15(28)18(30)25-6-5-20(21,22)23/h10,15,24,26H,4-9H2,1-3H3,(H,25,30)/t15-/m1/s1 | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | (2~{R})-1-[4-(4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]-~{N}-[3,3,3-tris(fluoranyl)propyl]piperazine-2-carboxamide |
|
| GIU | Name: | ~{N}-[(3~{S})-pyrrolidin-3-yl]isoquinoline-5-sulfonamide | Formula: | C13 H15 N3 O2 S | SMILES: | O=[S](=O)(N[CH]1CCNC1)c2cccc3cnccc23 | InChi: | InChI=1S/C13H15N3O2S/c17-19(18,16-11-4-6-15-9-11)13-3-1-2-10-8-14-7-5-12(10)13/h1-3,5,7-8,11,15-16H,4,6,9H2/t11-/m0/s1 | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | ~{N}-[(3~{S})-pyrrolidin-3-yl]isoquinoline-5-sulfonamide |
|
| GIZ | Name: | 1-[4-ethyl-5-[2-[4-[(1-ethylpiperidin-4-yl)methyl]piperazin-1-yl]-1,3-thiazol-4-yl]-2-methyl-1~{H}-pyrrol-3-yl]ethanone | Formula: | C24 H37 N5 O S | SMILES: | CCN1CCC(CC1)CN2CCN(CC2)c3scc(n3)c4[nH]c(C)c(C(C)=O)c4CC | InChi: | InChI=1S/C24H37N5OS/c1-5-20-22(18(4)30)17(3)25-23(20)21-16-31-24(26-21)29-13-11-28(12-14-29)15-19-7-9-27(6-2)10-8-19/h16,19,25H,5-15H2,1-4H3 | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 1-[4-ethyl-5-[2-[4-[(1-ethylpiperidin-4-yl)methyl]piperazin-1-yl]-1,3-thiazol-4-yl]-2-methyl-1~{H}-pyrrol-3-yl]ethanone |
|
| GJ4 | Name: | (2~{R})-1-[4-(4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]-~{N}-(4-oxidanylbutyl)piperazine-2-carboxamide | Formula: | C21 H31 N5 O3 S | SMILES: | CCc1c([nH]c(C)c1C(C)=O)c2csc(n2)N3CCNC[CH]3C(=O)NCCCCO | InChi: | InChI=1S/C21H31N5O3S/c1-4-15-18(14(3)28)13(2)24-19(15)16-12-30-21(25-16)26-9-8-22-11-17(26)20(29)23-7-5-6-10-27/h12,17,22,24,27H,4-11H2,1-3H3,(H,23,29)/t17-/m1/s1 | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | (2~{R})-1-[4-(4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]-~{N}-(4-oxidanylbutyl)piperazine-2-carboxamide |
|
| GJC | Name: | 2-[4-[[4-[4-(4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]piperazin-1-yl]methyl]-1,2,3-triazol-1-yl]ethanamide | Formula: | C21 H28 N8 O2 S | SMILES: | CCc1c([nH]c(C)c1C(C)=O)c2csc(n2)N3CCN(CC3)Cc4cn(CC(N)=O)nn4 | InChi: | InChI=1S/C21H28N8O2S/c1-4-16-19(14(3)30)13(2)23-20(16)17-12-32-21(24-17)28-7-5-27(6-8-28)9-15-10-29(26-25-15)11-18(22)31/h10,12,23H,4-9,11H2,1-3H3,(H2,22,31) | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 2-[4-[[4-[4-(4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrol-2-yl)-1,3-thiazol-2-yl]piperazin-1-yl]methyl]-1,2,3-triazol-1-yl]ethanamide |
|
| GJI | Name: | 3-methyl-1-(2-piperazin-1-yl-1,3-thiazol-4-yl)-2,5,6,7-tetrahydroisoindol-4-one | Formula: | C16 H20 N4 O S | SMILES: | Cc1[nH]c(c2CCCC(=O)c12)c3csc(n3)N4CCNCC4 | InChi: | InChI=1S/C16H20N4OS/c1-10-14-11(3-2-4-13(14)21)15(18-10)12-9-22-16(19-12)20-7-5-17-6-8-20/h9,17-18H,2-8H2,1H3 | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 3-methyl-1-(2-piperazin-1-yl-1,3-thiazol-4-yl)-2,5,6,7-tetrahydroisoindol-4-one |
|
| GKI | Name: | 1-[2-methyl-4-(3-methylbutyl)-5-(2-piperazin-1-yl-1,3-thiazol-4-yl)-1~{H}-pyrrol-3-yl]ethanone | Formula: | C19 H28 N4 O S | SMILES: | CC(C)CCc1c([nH]c(C)c1C(C)=O)c2csc(n2)N3CCNCC3 | InChi: | InChI=1S/C19H28N4OS/c1-12(2)5-6-15-17(14(4)24)13(3)21-18(15)16-11-25-19(22-16)23-9-7-20-8-10-23/h11-12,20-21H,5-10H2,1-4H3 | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 1-[2-methyl-4-(3-methylbutyl)-5-(2-piperazin-1-yl-1,3-thiazol-4-yl)-1~{H}-pyrrol-3-yl]ethanone |
|
| GQF | Name: | 1-[4-cyclopentyl-2-methyl-5-(2-piperazin-1-yl-1,3-thiazol-4-yl)-1~{H}-pyrrol-3-yl]ethanone | Formula: | C19 H26 N4 O S | SMILES: | CC(=O)c1c(C)[nH]c(c2csc(n2)N3CCNCC3)c1C4CCCC4 | InChi: | InChI=1S/C19H26N4OS/c1-12-16(13(2)24)17(14-5-3-4-6-14)18(21-12)15-11-25-19(22-15)23-9-7-20-8-10-23/h11,14,20-21H,3-10H2,1-2H3 | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 1-[4-cyclopentyl-2-methyl-5-(2-piperazin-1-yl-1,3-thiazol-4-yl)-1~{H}-pyrrol-3-yl]ethanone |
|
| GQX | Name: | 2-[4-(3-methyl-4-oxidanylidene-2,5,6,7-tetrahydroisoindol-1-yl)-1,3-thiazol-2-yl]guanidine | Formula: | C13 H15 N5 O S | SMILES: | Cc1[nH]c(c2CCCC(=O)c12)c3csc(N=C(N)N)n3 | InChi: | InChI=1S/C13H15N5OS/c1-6-10-7(3-2-4-9(10)19)11(16-6)8-5-20-13(17-8)18-12(14)15/h5,16H,2-4H2,1H3,(H4,14,15,17,18) | Definition date: | 2022-02-03 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 2-[4-(3-methyl-4-oxidanylidene-2,5,6,7-tetrahydroisoindol-1-yl)-1,3-thiazol-2-yl]guanidine |
|
| I1A | Name: | dimethyl 2-[[2-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]methyl]-2-prop-2-enyl-propanedioate | Formula: | C23 H29 N O6 | SMILES: | COC(=O)C(CC=C)(Cc1c(C)n(C(=O)OC(C)(C)C)c2ccccc12)C(=O)OC | InChi: | InChI=1S/C23H29NO6/c1-8-13-23(19(25)28-6,20(26)29-7)14-17-15(2)24(21(27)30-22(3,4)5)18-12-10-9-11-16(17)18/h8-12H,1,13-14H2,2-7H3 | Definition date: | 2022-05-30 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | dimethyl 2-[[2-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]methyl]-2-prop-2-enyl-propanedioate |
|
| I5G | Name: | 1-chloranyl-~{N}-[(~{S})-(3-chloranyl-4-cyano-phenyl)-[(2~{R},4~{S})-4-oxidanylpyrrolidin-2-yl]methyl]-7-methoxy-isoquinoline-6-carboxamide | Formula: | C23 H20 Cl2 N4 O3 | SMILES: | COc1cc2c(Cl)nccc2cc1C(=O)N[CH]([CH]3C[CH](O)CN3)c4ccc(C#N)c(Cl)c4 | InChi: | InChI=1S/C23H20Cl2N4O3/c1-32-20-9-16-12(4-5-27-22(16)25)6-17(20)23(31)29-21(19-8-15(30)11-28-19)13-2-3-14(10-26)18(24)7-13/h2-7,9,15,19,21,28,30H,8,11H2,1H3,(H,29,31)/t15-,19+,21-/m0/s1 | Definition date: | 2022-06-10 | Last modified: | 2022-09-23 | Release date: | 2022-09-28 | Identifier: | 1-chloranyl-~{N}-[(~{S})-(3-chloranyl-4-cyano-phenyl)-[(2~{R},4~{S})-4-oxidanylpyrrolidin-2-yl]methyl]-7-methoxy-isoquinoline-6-carboxamide |
|
| U90 | Name: | 3-O-methyl-alpha-D-mannopyranose | Formula: | C7 H14 O6 | SMILES: | OC1C(OC)C(O)C(CO)OC1O | InChi: | InChI=1S/C7H14O6/c1-12-6-4(9)3(2-8)13-7(11)5(6)10/h3-11H,2H2,1H3/t3-,4-,5+,6+,7+/m1/s1 | Definition date: | 2022-08-10 | Last modified: | 2022-09-16 | Release date: | 2022-09-21 | Identifier: | 3-O-methyl-alpha-D-mannopyranose |
|
| YPV | Name: | 5-[(4-butylphenyl)sulfamoyl]-2-hydroxybenzoic acid | Formula: | C17 H19 N O5 S | SMILES: | Oc1ccc(cc1C(=O)O)S(=O)(=O)Nc1ccc(CCCC)cc1 | InChi: | InChI=1S/C17H19NO5S/c1-2-3-4-12-5-7-13(8-6-12)18-24(22,23)14-9-10-16(19)15(11-14)17(20)21/h5-11,18-19H,2-4H2,1H3,(H,20,21) | Definition date: | 2021-03-19 | Last modified: | 2022-09-16 | Release date: | 2022-09-21 | Identifier: | 5-[(4-butylphenyl)sulfamoyl]-2-hydroxybenzoic acid |
|
| YQ1 | Name: | 1-(tripentyl-$l^{4}-azanyl)pentane | Formula: | C20 H44 N | SMILES: | CCCCC[N](CCCCC)(CCCCC)CCCCC | InChi: | InChI=1S/C20H44N/c1-5-9-13-17-21(18-14-10-6-2,19-15-11-7-3)20-16-12-8-4/h5-20H2,1-4H3 | Definition date: | 2021-03-22 | Last modified: | 2022-09-16 | Release date: | 2022-09-21 | Identifier: | 1-(tripentyl-$l^{4}-azanyl)pentane |
|
| YQ4 | Name: | (~{R})-phenyl-[4-[(tributyl-$l^{4}-azanyl)methyl]phenyl]methanol | Formula: | C26 H40 N O | SMILES: | CCCC[N](CCCC)(CCCC)Cc1ccc(cc1)[CH](O)c2ccccc2 | InChi: | InChI=1S/C26H40NO/c1-4-7-19-27(20-8-5-2,21-9-6-3)22-23-15-17-25(18-16-23)26(28)24-13-11-10-12-14-24/h10-18,26,28H,4-9,19-22H2,1-3H3/t26-/m1/s1 | Definition date: | 2021-03-22 | Last modified: | 2022-09-16 | Release date: | 2022-09-21 | Identifier: | (~{R})-phenyl-[4-[(tributyl-$l^{4}-azanyl)methyl]phenyl]methanol |
|
| UBH | Name: | 3-O-methyl-alpha-D-rhamnopyranose | Formula: | C7 H14 O5 | SMILES: | OC1C(OC)C(O)C(C)OC1O | InChi: | InChI=1S/C7H14O5/c1-3-4(8)6(11-2)5(9)7(10)12-3/h3-10H,1-2H3/t3-,4-,5+,6+,7+/m1/s1 | Synonyms: | 6-deoxy-3-O-methyl-alpha-D-mannopyranose | Definition date: | 2022-08-16 | Last modified: | 2022-09-16 | Release date: | 2022-09-21 | Identifier: | 6-deoxy-3-O-methyl-alpha-D-mannopyranose |
|